
Varex Imaging (NASDAQ:VREX) Releases Q1 2026 Earnings Guidance

Varex Imaging (NASDAQ:VREX) updated its Q1 2026 earnings guidance, projecting EPS of $0.050-0.250, below the consensus estimate of $0.170. Revenue guidance is set at $200-$215 million, compared to the consensus of $206.5 million. The stock rose $0.43 to $11.86, with a market cap of $492.19 million. Analysts have mixed ratings, with a consensus "Hold" and an average target price of $19.50.
Varex Imaging (NASDAQ:VREX - Get Free Report) issued an update on its first quarter 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.050-0.250 for the period, compared to the consensus EPS estimate of 0.170. The company issued revenue guidance of $200.0 million-$215.0 million, compared to the consensus revenue estimate of $206.5 million.
Get Varex Imaging alerts:
Varex Imaging Price Performance
NASDAQ:VREX traded up $0.43 during trading hours on Tuesday, reaching $11.86. 873,584 shares of the company's stock were exchanged, compared to its average volume of 423,064. The company has a market capitalization of $492.19 million, a P/E ratio of -3.69 and a beta of 0.98. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $16.93. The company has a quick ratio of 1.82, a current ratio of 3.51 and a debt-to-equity ratio of 0.78. The business's 50-day simple moving average is $11.83 and its two-hundred day simple moving average is $9.82.
Analysts Set New Price Targets
VREX has been the topic of a number of recent analyst reports. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Varex Imaging in a research report on Wednesday, October 8th. Wall Street Zen downgraded Varex Imaging from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Finally, B. Riley reaffirmed a "buy" rating and set a $16.00 price objective (up from $12.00) on shares of Varex Imaging in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $19.50.
Get Our Latest Analysis on Varex Imaging
Institutional Investors Weigh In On Varex Imaging
Institutional investors have recently bought and sold shares of the business. Quarry LP acquired a new position in shares of Varex Imaging in the 3rd quarter valued at about $64,000. BNP Paribas Financial Markets grew its position in Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company's stock valued at $113,000 after purchasing an additional 2,036 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in Varex Imaging in the 3rd quarter valued at approximately $117,000. Cerity Partners LLC acquired a new position in Varex Imaging in the 2nd quarter valued at approximately $123,000. Finally, The Manufacturers Life Insurance Company lifted its position in Varex Imaging by 10.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company's stock worth $133,000 after buying an additional 1,442 shares in the last quarter.
Varex Imaging Company Profile
(Get Free Report)Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Read More
- Five stocks we like better than Varex Imaging
- What is the Nikkei 225 index?
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
- Retail Stocks Investing, Explained
- Amazon Just Did This—and It Didn't End Well Last Time
- How to Evaluate a Stock Before Buying
- Stellantis Makes a High-Stakes Bet on Jeep
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Varex Imaging Right Now?
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

